Baxalta-Coherus Enbrel biosimilar succeeds in late-stage study

(Reuters) - Baxalta Inc and Coherus Biosciences Inc said their experimental biosimilar of Amgen Inc's arthritis drug Enbrel met the main goal in a late-stage study.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro